Pemberton, the diversified asset manager backed by one of Europe’s largest insurers, Legal & General Group PLC, today announces that it has acted as a sole lender for Spanish clinical and genetic laboratory business, Laboratorios Larrasa, as it continues its impressive growth plans.
Founded in 2002 and headquartered in La Albuera, Spain, Laboratorios Larrasa is an international leading clinical and genetic laboratory business. The capital provided by Pemberton comprises a Term Loan and a Capex Facility that will be used both to refinance the business’ existing debt and to support expansion of its operations, specifically its work in identifying genetic markers in animals.
Cassandra Rivilla-Lutterkort, Director of Origination for UK and Spain at Pemberton, said, “Laboratorios Larrasa has undergone significant growth since its founding back in 2002 and we are pleased to be providing new capital for the business as it enters the next stage of its development. This deal marks Pemberton’s 4th transaction in Spain this year, as we continue to embed ourselves in the market.”
José Larrasa, CEO and Founder of Laboratorios Larrasa, said: “This transaction is a very important milestone in the journey of the Company as we seek to better serve our key customers and expand our operations. We considered various financing routes and decided to partner with Pemberton due to the combination of their thoughtful structuring, focus on understanding the business and ability to provide long-term capital.”
Laboratorios Larrasa was advised by Meridium GM Partners, Deloitte, KPMG and PwC. Pemberton was advised by DLA Piper.
Copyright © 2020 Pemberton Capital Advisors LLP
Authorised and regulated by the Financial Conduct Authority